Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

January 15, 2025

Study Completion Date

January 21, 2025

Conditions
Prostate Hyperplasia
Interventions
DEVICE

iTind device

Cystoscopy will be performed to assess the anatomy of the bladder and prostate. The iTind device would be inserted under visual guidance into the bladder. The device will then be deployed and under visual guidance, it will be positioned at the prostatic lumen. After confirming the position of the device, cystoscopy will be withdrawn and the position will be finished.

Trial Locations (1)

Unknown

Prince of Wales Hospital, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER